Sacyr, S.A. (BME:SCYR)

Achilles Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,943	2,464	2,021	1,658	1,402	1,187
Market Cap Growth	19.95%	21.93%	21.88%	18.22%	18.10%	-19.23%
Enterprise Value	10,727	10,150	11,078	10,087	8,078	8,052
Last Close Price	3.72	3.08	2.92	2.34	1.98	1.69
PE Ratio	31.95	21.73	13.19	15.00	-	33.27
Forward PE	15.63	13.87	15.18	13.68	11.12	8.51
PS Ratio	0.63	0.54	0.44	0.33	0.30	0.26
PB Ratio	1.43	1.20	1.16	1.22	1.46	1.23
P/TBV Ratio	3.59	2.69	2.88	4.97	6.88	2.77
P/FCF Ratio	-	2.56	3.24	13.74	3.28	2.90
P/OCF Ratio	-	1.90	2.38	2.35	2.23	2.18
PEG Ratio	0.94	1.23	0.18	0.18	0.23	0.23
EV/Sales Ratio	2.29	2.22	2.40	2.02	1.72	1.77
EV/EBITDA Ratio	7.86	7.51	8.01	7.22	9.47	13.13
EV/EBIT Ratio	8.83	8.36	8.82	7.90	11.10	17.24
EV/FCF Ratio	-	10.56	17.74	83.59	18.87	19.63
Debt / Equity Ratio	4.02	4.43	4.97	7.28	9.06	7.84
Debt / EBITDA Ratio	6.18	6.65	6.16	6.94	9.91	11.76
Debt / FCF Ratio	-	9.49	13.92	81.96	20.31	18.41
Asset Turnover	0.27	0.26	0.27	0.31	0.32	0.32
Inventory Turnover	9.21	7.52	6.73	8.93	7.98	7.44
Quick Ratio	0.85	0.85	0.80	1.20	1.06	0.84
Current Ratio	1.14	1.14	1.09	1.27	1.11	0.98
Return on Equity (ROE)	13.61%	13.52%	2.53%	28.85%	-10.57%	10.30%
Return on Assets (ROA)	4.21%	4.30%	4.50%	4.91%	3.10%	2.06%
Return on Capital (ROIC)	7.18%	7.02%	7.24%	7.64%	5.01%	3.31%
Return on Capital Employed (ROCE)	10.10%	10.10%	11.40%	9.70%	6.90%	4.70%
Earnings Yield	3.13%	4.60%	7.58%	6.67%	-13.49%	3.01%
FCF Yield	-	39.02%	30.89%	7.28%	30.52%	34.54%
Dividend Yield	4.22%	5.09%	4.79%	5.30%	5.20%	4.03%
Payout Ratio	-	36.72%	24.32%	35.69%	-	94.72%
Buyback Yield / Dilution	-	-5.48%	-2.53%	-1.03%	-16.60%	-3.59%
Total Shareholder Return	4.34%	-0.39%	2.26%	4.27%	-11.40%	0.44%

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.